Bank of America Corp DE Has $2.92 Million Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Bank of America Corp DE grew its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 30.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 396,662 shares of the company's stock after acquiring an additional 91,796 shares during the period. Bank of America Corp DE owned 0.10% of LifeStance Health Group worth $2,923,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Jennison Associates LLC boosted its position in LifeStance Health Group by 278.4% during the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after purchasing an additional 5,949,438 shares during the last quarter. Handelsbanken Fonder AB acquired a new stake in shares of LifeStance Health Group during the 4th quarter valued at about $128,000. Blue Trust Inc. grew its stake in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after buying an additional 2,122 shares in the last quarter. Northern Trust Corp grew its stake in shares of LifeStance Health Group by 11.7% in the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock valued at $11,731,000 after buying an additional 166,731 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock worth $25,546,000 after buying an additional 13,293 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

LFST has been the subject of a number of analyst reports. KeyCorp assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective for the company. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a research report on Tuesday, May 27th. One investment analyst has rated the stock with a sell rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Stock Performance

LFST stock traded down $0.01 during midday trading on Wednesday, hitting $5.95. 1,336,157 shares of the company traded hands, compared to its average volume of 1,595,999. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The stock has a market capitalization of $2.31 billion, a price-to-earnings ratio of -22.88 and a beta of 1.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The business has a 50 day simple moving average of $6.28 and a 200-day simple moving average of $7.10.

Insider Transactions at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. The trade was a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 3.20% of the stock is owned by corporate insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.